These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35689900)

  • 1. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks.
    Liu C; Huang R; Yu H; Gong Y; Wu P; Feng Q; Li X
    Phytomedicine; 2022 Aug; 103():154226. PubMed ID: 35689900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms.
    Li X; Yu H; Gong Y; Wu P; Feng Q; Liu C
    J Ethnopharmacol; 2022 Feb; 284():114801. PubMed ID: 34748868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies.
    Liu C; Yu H; Li X; Gong Y; Wu P; Feng QS
    J Ethnopharmacol; 2022 Mar; 285():114913. PubMed ID: 34910953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
    Lin X; Chen Y
    Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 6. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma.
    Xiong DD; Dang YW; Lin P; Wen DY; He RQ; Luo DZ; Feng ZB; Chen G
    J Transl Med; 2018 Aug; 16(1):220. PubMed ID: 30092792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput circular RNA sequencing reveals the profiles of circular RNA in non-cirrhotic hepatocellular carcinoma.
    Li H; Xu L; Yi P; Li L; Yan T; Xie L; Zhu Z
    BMC Cancer; 2022 Aug; 22(1):857. PubMed ID: 35931993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis.
    Sun X; Ge X; Xu Z; Chen D
    J Gastroenterol Hepatol; 2020 Jan; 35(1):157-164. PubMed ID: 31222831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells.
    Chen KH; Pan JF; Chen ZX; Pan D; Gao T; Huang M; Huang JN
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4161-4171. PubMed ID: 32373952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a ceRNA regulatory network to explore potential pathogenesis mechanisms involved in human hepatocellular carcinoma.
    Liu Y; Dong Z; Chen W; Chen L; Ju L; Cai W; Luo X; Bian Z
    Sci Rep; 2023 Dec; 13(1):22058. PubMed ID: 38086834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
    Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
    Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma.
    Mo M; Liu B; Luo Y; Tan JHJ; Zeng X; Zeng X; Huang D; Li C; Liu S; Qiu X
    Front Mol Biosci; 2022; 9():801478. PubMed ID: 35141281
    [No Abstract]   [Full Text] [Related]  

  • 14. Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma.
    Yang J; Li Y; Yu Z; Zhou Y; Tu J; Lou J; Wang Y
    Mol Med Rep; 2020 Jun; 21(6):2395-2404. PubMed ID: 32323783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of RNA-seq in hepatocellular carcinoma reveals competing endogenous RNA network composed of circRNA, lncRNA, and mRNA.
    Zhou F; Kang Q; Ma J; Cai J; Chen Y; Qu K; Li F
    Medicine (Baltimore); 2023 Feb; 102(8):e32915. PubMed ID: 36827016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a circRNA-miRNA-mRNA network based on differentially co-expressed circular RNA in gastric cancer tissue and plasma by bioinformatics analysis.
    Gong Y; Jiao Y; Qi X; Fu J; Qian J; Zhu J; Yang H; Tang L
    World J Surg Oncol; 2022 Feb; 20(1):34. PubMed ID: 35164778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and Bioinformatics Analysis of Competitive Endogenous RNA Regulatory Network --Related to Circular RNA in Breast Cancer.
    Wang T; Zhang Y; He Y; Liu Y; Qi P
    Biomed Res Int; 2021; 2021():5575286. PubMed ID: 34545330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
    Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
    Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of CircRNA1002 as a biomarker in hepatitis B virus-related hepatocellular carcinoma.
    Li Y; Li R; Cheng D; Fu X; Fu L; Peng S
    PeerJ; 2022; 10():e13640. PubMed ID: 35782101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.